genspera.com Inspyr Therapeutics , Inc. ( OTC : NSPX) is a development-stage pharmaceutical company based in San Antonio, Texas. The company is focused on therapeutics that deliver a cancer-destroying drug directly to the tumor or its supporting environment, the tumor vasculature.

2008年1月31日 · Inspyr Therapeutics, Inc., formerly GenSpera, Inc., is an integrated biopharmaceutical company. The Company is focused on the development of therapies to treat cancer, inflammation, and other diseases.

2021年1月12日 · WESTLAKE VILLAGE, CA / ACCESSWIRE / January 12, 2021 / Inspyr (Formerly Known As GenSpera), Inc. (OTC PINK:NSPX), a pharmaceutical company focused on the research and development of novel targeted precision therapeutics for the treatment of cancer, announces the sale of $500,000 of a senior convertible debenture (“Debenture”) from an ...

Inspyr Therapeutics, Inc., formerly GenSpera, Inc., is an integrated biopharmaceutical company. The Company is focused on the development of therapies to treat cancer, inflammation, and other ...

2016年8月1日 · San Antonio biotech company GenSpera Inc., which has been working to develop target-specific cancer drugs, revealed today that it will change its name to Inspyr Therapeutics Inc.

2016年8月1日 · Inspyr Therapeutics, Inc. (formerly known as GenSpera, Inc.) is developing a novel technology platform that combines a powerful cytotoxin (thapsigargin) with a patented prodrug delivery...

GenSpera’s technology platform combines a powerful, plant-derived cytotoxin (thapsigargin) with a prodrug delivery system that provides for the targeted release of drug candidates within a...

On August 1, 2016, GenSpera, Inc. announced it is changing it corporate name to Inspyr

Contact Email [email protected] Phone Number 210.479.8112 Inspyr Therapeutics is a development stage company, focuses on the development of targeted cancer therapeutics for the treatment of cancerous tumors, including breast, prostate, bladder, and kidney cancer.

2015年5月13日 · GenSpera's technology platform combines a powerful, plant-derived cytotoxin (thapsigargin) with a patented prodrug delivery system that provides for targeted release of drug candidates...